BioSpecifics Technologies Corp. Bookmark and Share

ArticleDateSource
BioSpecifics Technologies Corporation (BSTC) to Host Conference Call to Report Second Quarter 2011 Financial Results on August 9,--Biotechnology - Moreover
BioSpecifics Technologies Corp. Reports First Quarter 2012 Financial ResultsMay 10, 2012Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Initiation of Phase II Trial for Canine LipomasMay 07, 2012Medical Pharma - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2011 Financial Results on March 9, 2012March 02, 2012Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in MarchFebruary 29, 2012Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of DirectorsDecember 09, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare ConferenceNovember 09, 2011Biotech News - PR Newswire
Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®August 31, 2011Clinical Trials - PR Newswire
BioSpecifics Technologies Corp. Reports Second Quarter 2011 Financial ResultsAugust 09, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2011 Financial Results on August 9, 2011August 02, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corporation (BSTC) to Present at Jefferies and Co.June 03, 2011Biotechnology - Moreover
BioSpecifics Technologies Corp. to Present at Jefferies 2011 Global Healthcare ConferenceJune 02, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EUMay 20, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand MeetingMay 18, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity ConferenceMay 11, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial ResultsMay 10, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2011 Financial ResultsMay 04, 2011Pharma News - PR Newswire
BioSpecifics Technologies Corp. to Present at BioCentury Future Leaders in the Biotech Industry ConferenceApril 13, 2011Medical Pharma - PR Newswire
BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytren's Contracture in EuropeApril 11, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corporation (BSTC) to Present at the Roth Capital PartnersMarch 12, 2011Biotechnology - Moreover
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial ResultsMarch 11, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock ConferenceMarch 10, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011March 08, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care ConferenceMarch 03, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Approval of XIAPEX® for Treatment of Dupuytren's Contracture in EuropeMarch 01, 2011Pharma News - PR Newswire
BioSpecifics Technologies Corp. Amends Its Rights AgreementFebruary 07, 2011Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 7th Annual Healthcare ConferenceNovember 10, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corp. Reports Third Quarter 2010 Financial ResultsNovember 08, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corporation Awarded Two Qualifying Therapeutic Discovery Project Grants November 04, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project GrantsNovember 03, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2010 Financial Results on November 8, 2010November 01, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry ConferenceOctober 14, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corporation Announces Initiation of Global Phase 3 Trial of XIAFLEX(R) for Treatment of Peyronie's Disease October 13, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronie's DiseaseOctober 12, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corp. to Present at UBS Global Life Sciences ConferenceSeptember 14, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare ConferenceSeptember 08, 2010Biotech News - PR Newswire
Urgent Pharmaceutical Stock News Alerts: Axxess Pharma, Inc. & BioSpecifics Technologies Corp.August 09, 2010Pharmaceutical - Moreover
BioSpecifics Technologies Corp. Reports Second Quarter 2010 Financial ResultsAugust 06, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corporation to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 July 30, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010July 30, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® UpdateJuly 12, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corporation Announces Board Authorization of up to $2 Million Share Repurchase Program June 04, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase ProgramJune 04, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corp. to Present at Jefferies & Company 2010 Global Life Sciences ConferenceJune 02, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. Reports First Quarter 2010 Financial ResultsMay 07, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2010 Financial Results on May 7, 2010May 03, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corporation Announces 2010 Annual Meeting Date and Proposal to Increase the Number of Authorized Shares of Common Stock March 26, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces 2010 Annual Meeting Date and Proposal to Increase the Number of Authorized Shares of Common StockMarch 25, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corporation Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture March 09, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's ContractureMarch 08, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on March 10, 2010March 05, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. to Present at Cowen and Company 30th Annual Health Care ConferenceMarch 01, 2010Biotech News - PR Newswire
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's ContractureFebruary 03, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corporation Announces Commencement of European Regulatory Review of XIAFLEX(TM) for the Treatment of Dupuytren's Disease January 21, 2010BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces Commencement of European Regulatory Review of XIAFLEX(TM) for the Treatment of Dupuytren's DiseaseJanuary 21, 2010Pharma News - PR Newswire
BioSpecifics Technologies Corporation Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease December 16, 2009BioSpace - Breaking News
BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's DiseaseDecember 16, 2009Biotech News - PR Newswire



View all the latest news